Indoco Remedies Management
Management criteria checks 3/4
Indoco Remedies' CEO is Sundeep Bambolkar, appointed in Feb 2012, has a tenure of 12.75 years. total yearly compensation is ₹75.54M, comprised of 61.7% salary and 38.3% bonuses, including company stock and options. directly owns 0.18% of the company’s shares, worth ₹54.82M. The average tenure of the management team and the board of directors is 7.9 years and 14 years respectively.
Key information
Sundeep Bambolkar
Chief executive officer
₹75.5m
Total compensation
CEO salary percentage | 61.7% |
CEO tenure | 12.8yrs |
CEO ownership | 0.2% |
Management average tenure | 7.9yrs |
Board average tenure | 14yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹321m |
Jun 30 2024 | n/a | n/a | ₹767m |
Mar 31 2024 | ₹76m | ₹47m | ₹985m |
Dec 31 2023 | n/a | n/a | ₹1b |
Sep 30 2023 | n/a | n/a | ₹1b |
Jun 30 2023 | n/a | n/a | ₹1b |
Mar 31 2023 | ₹65m | ₹40m | ₹1b |
Dec 31 2022 | n/a | n/a | ₹2b |
Sep 30 2022 | n/a | n/a | ₹2b |
Jun 30 2022 | n/a | n/a | ₹2b |
Mar 31 2022 | ₹46m | ₹30m | ₹2b |
Dec 31 2021 | n/a | n/a | ₹1b |
Sep 30 2021 | n/a | n/a | ₹1b |
Jun 30 2021 | n/a | n/a | ₹1b |
Mar 31 2021 | ₹28m | ₹20m | ₹930m |
Dec 31 2020 | n/a | n/a | ₹734m |
Sep 30 2020 | n/a | n/a | ₹571m |
Jun 30 2020 | n/a | n/a | ₹393m |
Mar 31 2020 | ₹18m | ₹15m | ₹241m |
Dec 31 2019 | n/a | n/a | ₹302m |
Sep 30 2019 | n/a | n/a | ₹264m |
Jun 30 2019 | n/a | n/a | ₹111m |
Mar 31 2019 | ₹15m | ₹12m | -₹29m |
Mar 31 2018 | ₹16m | ₹12m | ₹412m |
Compensation vs Market: Sundeep's total compensation ($USD892.66K) is above average for companies of similar size in the Indian market ($USD266.16K).
Compensation vs Earnings: Sundeep's compensation has been consistent with company performance over the past year.
CEO
Sundeep Bambolkar (64 yo)
12.8yrs
Tenure
₹75,540,000
Compensation
Mr. Sundeep Vasant Bambolkar has been a Joint Managing Director at Indoco Remedies Limited since February 15, 2012. Mr. Bambolkar served as Chief Financial Officer at Indoco Remedies Limited from March 23,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Non-Executive Chairman & Whole time Director | 61.3yrs | ₹36.89m | 4.7% ₹ 1.4b | |
Joint MD & Executive Director | 12.8yrs | ₹75.54m | 0.18% ₹ 54.8m | |
MD & Executive Director | 12.8yrs | ₹85.42m | 6.15% ₹ 1.8b | |
Chief Financial Officer | 3yrs | ₹17.38m | no data | |
GM of Legal | 1.9yrs | ₹5.48m | no data | |
Chief Technical Officer | no data | ₹7.57m | no data | |
President of Sales & Marketing | no data | no data | no data | |
Chief Marketing Officer | no data | no data | no data | |
Vice President of Corporate HR | no data | no data | no data | |
Head of OSD | no data | no data | no data | |
Executive Vice President of International Business for Regulated Markets | no data | no data | no data | |
Senior Vice President of Sales for API | no data | no data | no data |
7.9yrs
Average Tenure
60.5yo
Average Age
Experienced Management: 532612's management team is seasoned and experienced (7.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Non-Executive Chairman & Whole time Director | 61.3yrs | ₹36.89m | 4.7% ₹ 1.4b | |
Joint MD & Executive Director | 20.7yrs | ₹75.54m | 0.18% ₹ 54.8m | |
MD & Executive Director | 20.7yrs | ₹85.42m | 6.15% ₹ 1.8b | |
Independent Non-Executive Director | 19.6yrs | ₹580.00k | no data | |
Independent Non-Executive Director | 17.6yrs | ₹660.00k | 0.013% ₹ 3.9m | |
Non-Executive Director | 10.5yrs | ₹360.00k | no data | |
Non-Executive & Independent Director | 4.7yrs | ₹500.00k | no data | |
Independent Non-Executive Director | 4.1yrs | ₹460.00k | 0.0054% ₹ 1.6m | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data |
14.0yrs
Average Tenure
67yo
Average Age
Experienced Board: 532612's board of directors are seasoned and experienced ( 14 years average tenure).